Skip to content

Cerclage for Twins With Short Cervical Length ≤ 15mm

Cervical Cerclage for Preventing Spontaneous Preterm Birth in Twin Pregnancies With Transvaginal Ultrasound Cervical Length ≤ 15mm: a Study Protocol for a Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03340688
Acronym
TWIN-UIC
Enrollment
200
Registered
2017-11-13
Start date
2017-06-22
Completion date
2025-06-30
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix

Brief summary

This is a multicenter randomized study designed to determine if ultrasound indicated cerclage reduces the incidence of spontaneous preterm birth \<34 weeks in asymptomatic women with twin gestations and cervical length ≤15mm, diagnosed by transvaginal ultrasound between 16 to 23 6/7 weeks of gestation.

Detailed description

Twin pregnancies have 59% incidence of preterm delivery (before 37 weeks of gestation), with increased perinatal mortality and neonatal morbidity. No therapy has proven effective in preventing preterm birth in twins. The transvaginal cervical length (TVCL) performed before 24 weeks have been determined to be the best tool to identified women with twin pregnancy at risk of preterm birth (PTB). When short TVCL is identified before 24 weeks, the risk of preterm birth is 60%-70% for TVCL ≤25mm and 80%-90% for TVCL ≤15mm. There are a small number of case reports of cervical cerclage in twin pregnancies with cervical length ≤15mm that suggest decreased preterm birth by 80%. The investigators' objective is to determine if ultrasound indicated cerclage in reduces the incidence of spontaneous preterm birth \<34 weeks and improve perinatal outcome in asymptomatic women with twin gestations and cervical length ≤15mm between 16 to 23 6/7 weeks of gestation.

Interventions

Cervical cerclage indicated by short cervix ≤15mm

Sponsors

Federico II University
CollaboratorOTHER
Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Pregnant women more than 18 years of age (limits the participants to female gender) 2. Diamniotic twin pregnancy 3. Asymptomatic 4. Transvaginal cervical length ≤ 15 mm between 16-23 6/7 weeks gestation

Exclusion criteria

1. Singleton or higher order than twins multiple gestation 2. Transvaginal cervical length \>15mm 3. Cervical dilation with visible amniotic membranes 4. Amniotic membranes prolapsed into the vagina 5. Fetal reduction after 14 weeks form higher order 6. Monoamniotic twins 7. Twin-twin transfusion syndrome 8. Ruptured membranes 9. Major fetal structural anomaly 10. Fetal chromosomal abnormality 11. Cerclage already in place for other indication 12. Active vaginal bleeding 13. Clinical chorioamnionitis 14. Placenta previa 15. Painful regular uterine contractions 16. Labor

Design outcomes

Primary

MeasureTime frameDescription
Preterm delivery less than 34 weeksat deliveryIncidence of preterm birth less than 34 weeks (any indication)

Secondary

MeasureTime frameDescription
Preterm delivery less than <32 weeks, <28 weeks, or <24 weeksat deliveryIncidence of preterm birth less than \<32 weeks, \<28 weeks, or \<24 weeks
Mean gestational age at deliveryat deliveryMean value of gestational age at delivery (weeks)
Birth weight at birthat deliveryMean value (grams)
Gestational age at spontaneous rupture of membranesat deliveryMean value (weeks) through study completion
Premature rupture of membranesat deliveryIncidence
Spontaneous preterm birth ratesat deliveryIncidence of spontaneous preterm birth less than 34 weeks
Composite adverse neonatal outcomeIncidence between birth and 28 days of ageIncludes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis
Neonatal deathBetween birth and 28 days of ageIncidence
Maternal deathBetween birth and 6 weeks postpartumIncidence
Interval between diagnosis and deliveryat deliveryMean value (days) through study completion
Chorioamnionitisat deliveryIncidence

Countries

Egypt, Italy, Spain, United States

Contacts

Primary ContactAmanda Roman, MD
amanda.roman@jefferson.edu215.955.9200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026